In the fast-moving world of healthcare technology, 2026 marks a pivotal shift. Health systems across the nation are moving beyond initial pilots and proof-of-concept projects, attempting to fully operationalize artificial intelligence in daily clinical workflows. However, this transition is proving far more difficult than anticipated. A new report reveals that the very platforms designed to support modern medicine—electronic health records (EHR)—are ironically acting as significant bottlenecks to progress. For IT leadership, the strategy is no longer about testing what AI can do; it is about scaling those tools effectively, and they are finding their options constrained by the rigid ecosystems of their primary software providers.

At the core of the issue is vendor reliance. Nearly three-quarters of senior IT leaders now cite their dependency on EHR vendor roadmaps as a critical obstacle to their AI strategies. Many health systems have historically relied on their EHR providers to deliver the latest software enhancements. Yet, as the pace of AI innovation accelerates, many organizations realize they cannot afford to wait for these monolithic vendors to roll out feature updates. There is a tangible fear of 'late-mover disadvantage,' where health systems that wait for proprietary solutions risk falling behind competitors who have already successfully integrated third-party AI tools into their operations.

The data paints a striking picture of this shift in philosophy. While organizations were once content to wait for their EHR vendor to build specific AI functionality, that patience has evaporated. In 2025, over half of health systems were willing to wait for native EHR features; by 2026, that figure has plummeted to just 22%. Leaders are increasingly evaluating the clear trade-off between the stability of an integrated EHR feature and the agility of specialized third-party vendors. When faced with the choice of waiting 18 months for an EHR update versus deploying a high-ROI third-party tool in three months, nearly half of respondents are opting for the latter, choosing speed over centralized vendor dependency.

This decision to bypass the EHR vendor’s native roadmap introduces a new set of challenges: the management of a fragmented AI portfolio. Organizations are struggling with the 'vendor sprawl' that inevitably follows when they independently procure multiple specialized AI solutions. Two-thirds of respondents identified this complexity as a significant strain on their IT resources. Managing integration, security, and maintenance for a diverse array of vendors is consuming a massive slice of IT bandwidth. In some cases, organizations are dedicating up to half of their available IT capacity just to support the infrastructure required to manage these disparate AI tools.

Perhaps most concerning is the difficulty in justifying the costs. Measuring return on investment (ROI) remains elusive, with the vast majority of leaders reporting they lack clear benchmarks to evaluate the performance of their AI deployments. While 74% of systems require a clear ROI within a year to justify their investments, many do not expect to see financial returns for more than 13 months. This gap between the desire for quick, measurable results and the reality of long-term AI integration creates immense pressure on executive teams. It highlights a maturing industry where the conversation has moved from simple adoption to the grueling work of proving business value in a complex, risk-averse environment.

In the fast-moving world of healthcare technology, 2026 marks a pivotal shift. Health systems across the nation are moving beyond initial pilots and proof-of-concept projects, attempting to fully operationalize artificial intelligence in daily clinical workflows. However, this transition is proving far more difficult than anticipated. A new report reveals that the very platforms designed to support modern medicine—electronic health records (EHR)—are ironically acting as significant bottlenecks to progress. For IT leadership, the strategy is no longer about testing what AI can do; it is about scaling those tools effectively, and they are finding their options constrained by the rigid ecosystems of their primary software providers.

At the core of the issue is vendor reliance. Nearly three-quarters of senior IT leaders now cite their dependency on EHR vendor roadmaps as a critical obstacle to their AI strategies. Many health systems have historically relied on their EHR providers to deliver the latest software enhancements. Yet, as the pace of AI innovation accelerates, many organizations realize they cannot afford to wait for these monolithic vendors to roll out feature updates. There is a tangible fear of 'late-mover disadvantage,' where health systems that wait for proprietary solutions risk falling behind competitors who have already successfully integrated third-party AI tools into their operations.

The data paints a striking picture of this shift in philosophy. While organizations were once content to wait for their EHR vendor to build specific AI functionality, that patience has evaporated. In 2025, over half of health systems were willing to wait for native EHR features; by 2026, that figure has plummeted to just 22%. Leaders are increasingly evaluating the clear trade-off between the stability of an integrated EHR feature and the agility of specialized third-party vendors. When faced with the choice of waiting 18 months for an EHR update versus deploying a high-ROI third-party tool in three months, nearly half of respondents are opting for the latter, choosing speed over centralized vendor dependency.

This decision to bypass the EHR vendor’s native roadmap introduces a new set of challenges: the management of a fragmented AI portfolio. Organizations are struggling with the 'vendor sprawl' that inevitably follows when they independently procure multiple specialized AI solutions. Two-thirds of respondents identified this complexity as a significant strain on their IT resources. Managing integration, security, and maintenance for a diverse array of vendors is consuming a massive slice of IT bandwidth. In some cases, organizations are dedicating up to half of their available IT capacity just to support the infrastructure required to manage these disparate AI tools.

Perhaps most concerning is the difficulty in justifying the costs. Measuring return on investment (ROI) remains elusive, with the vast majority of leaders reporting they lack clear benchmarks to evaluate the performance of their AI deployments. While 74% of systems require a clear ROI within a year to justify their investments, many do not expect to see financial returns for more than 13 months. This gap between the desire for quick, measurable results and the reality of long-term AI integration creates immense pressure on executive teams. It highlights a maturing industry where the conversation has moved from simple adoption to the grueling work of proving business value in a complex, risk-averse environment.